• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Axplora`s Ursodeoxycholic Receives 5-Year Renewed Registration

    PRESS RELEASE

    Zaphyr Pharmaceuticals and Laboratoires CTRS enter into collaboration for the Middle East & North Africa region for 2 innovative products

    PRESS RELEASE

    Medac Gesellschaft`s Kolbam receive market authorisation in EU

    FDA

    FDA clears aramchol IND application for HIV-related lipodystrophy, NAFLD

    HEALIO

    T-452/14 Laboratoires CTRS v Commission Judgment

    LEXOLOGY

    Cerilliant Introduces Certified Spiking Solutions of Bile Acids

    PR NEWSWIRE

    Harvard Professor Ques Success of FDA`s Priority Review Voucher Program

    RAPS

    Sanofi pays $245m for FDA priority review voucher

    PM LIVE

    One, Two, Three . . . and They’re Out! FDA Issues Third Rare Pediatric Disease Priority Review Voucher, Triggering One-Year Sunset Clause

    FDA LAW BLOG

    Asklepion`s Cholbam (Cholic Acid) Approved in USA For Bile Acid Synthesis Disorders

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.